Scotland · NHS Scotland MSAN
Isosorbide mononitrate 10mg, 20mg and 40mg tablets (immediate-release)
MSAN(2024)68 · Level 2 · issued 27 Dec 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Isosorbide mononitrate 10mg and 20mg immediate-release (IR) tablets are in limited supply | Limited supply | — |
| 2. Isosorbide mononitrate 40mg IR tablets are out of stock until late February 2025. | Out of stock | late February 2025 |
| 3. Isosorbide mononitrate 30mg IR tablets remain available but cannot support any additional | Available — cannot support uplift | — |
| 25, 40, 50 and 60mg) remain available and can support an increased demand (except 60mg | Available | — |
| 5. Isosorbide dinitrate IR tablets remain available but can only support a limited increase in | Available — partial uplift only | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.